David Watson
Littleton, CONPI 1568420909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 35.9% of the total. Reporting peaked in 2022 at $433 and has fallen 95.5% since, to $19 in 2024.
Across 101 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$620
- Eisai Inc.$182
- Mayne Pharma Commercial LLC$124
- Bayer$92
- Ascend Therapeutics US, LLC$86
- Therapeuticsmd, Inc.$75
- plus $550 from 18 others
Across 2 payments — averaging $312,498 each. An ownership or investment interest held by the physician or an immediate family member.
- Vektor Medical Inc.$625K
What the payments were for
- Food & beverage$1,70599%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $620 |
| Eisai Inc. | 14 | $182 |
| Mayne Pharma Commercial LLC | 9 | $124 |
| Bayer | 4 | $92 |
| Ascend Therapeutics US, LLC | 6 | $86 |
| Therapeuticsmd, Inc. | 5 | $75 |
| Hologic Sales And Service, LLC | 3 | $74 |
| Vertical Pharmaceuticals, LLC | 3 | $64 |
| Merck | 3 | $49 |
| Astellas Pharma US Inc | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Avion Pharmaceuticals | 2 | $35 |
| Organon | 2 | $33 |
| Myovant Sciences Inc. | 1 | $27 |
| Dysis Medical, Inc. | 2 | $25 |
| Coloplast | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Pfizer | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Coopersurgical, Inc. | 1 | $14 |
| Lupin Inc. | 1 | $12 |
| Acelrx Pharmaceuticals, Inc. | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.